RecruitingNCT06468566

Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study

Identification of Benign and Malignant Breast Nodules Using Opalogram Ultrasonography: A Multicenter Study

Sponsor

Xin-Wu Cui

Enrollment

2,000 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Female

Summary

Ultrasonic light scattering imaging is a new functional imaging technology that combines traditional B-mode ultrasound imaging and light scattering tomography (DOT). It can improve the accuracy of early diagnosis of breast cancer based on the characteristics of abnormal blood supply and oxygen consumption of lesions. This study aims to evaluate the value of ultrasonic light scattering imaging in the differential diagnosis of benign and malignant breast nodules, and to evaluate the consistency between ultrasonic light scattering imaging and examiners in the differential diagnosis of benign and malignant breast nodules.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new imaging technology called ultrasound-modulated optical tomography to see if it can tell the difference between benign (non-cancerous) and malignant (cancerous) breast lumps — potentially reducing the need for invasive biopsies. **You may be eligible if...** - You are 18 or older and have a breast lump or lesion detected on ultrasound - You are scheduled for a needle biopsy or breast surgery - You are able to give informed consent **You may NOT be eligible if...** - You have already had a biopsy of the breast lesion before the ultrasound exam for this study - You are pregnant or breastfeeding - You are currently receiving chemotherapy before surgery (neoadjuvant treatment) - You cannot cooperate with the imaging procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.